GENVEC, INC.
Warrant To Purchase Common
Stock
Number of
Shares of Common Stock: 9,615,385
Date of
Issuance: May 29, 2009 (“ Issuance Date
”)
GenVec, Inc., a Delaware Corporation, (the
“ Company ”), hereby certifies that, for good
and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, ____________, the registered holder hereof
or its permitted assigns (the “ Holder ”), is
entitled, subject to the terms set forth below, to purchase from
the Company, at the Exercise Price (as defined below) then in
effect, upon surrender of this Warrant to Purchase Common Stock
(including any Warrants to Purchase Common Stock issued in
exchange, transfer or replacement hereof, the “
Warrant ”), at any time or times on or after November
29, 2009 (the “ Exercisability Date ”), but not
after 11:59 p.m., New York Time, on the Expiration Date (as defined
below) 9,615,385 fully paid and nonassessable shares of Common
Stock (as defined below) (the “ Warrant
Shares ”). Except as otherwise defined herein,
capitalized terms in this Warrant shall have the meanings set forth
in Section 14. This Warrant is one of a series of
warrants to purchase shares of Common Stock (the “ SPA
Warrants ” issued pursuant to those certain Purchase
Agreements, dated as of May 27, 2009 (the “ Subscription
Date ”), by and among the Company and the investors (the
“ Investors ”) referred to therein (the “
Purchase Agreements ”) pursuant to the Company’s
Registration Statement on Form S-3 (No. 333-140373) (the “
Registration Statement ”).
1. EXERCISE OF
WARRANT .
(a) Mechanics of
Exercise . Subject to the terms and conditions
hereof (including, without limitation, the limitations set forth in
Section 1(f)), this Warrant may be exercised by the Holder on any
day on or after the Exercisability Date, in whole or in part (but
not as to fractional shares), by (i) delivery of a written notice,
in the form attached hereto as Exhibit A (the “
Exercise Notice ”), of the Holder’s election to
exercise this Warrant and (ii) (A) payment to the Company of
an amount equal to the applicable Exercise Price multiplied by the
number of Warrant Shares as to which this Warrant is being
exercised (the “ Aggregate Exercise Price ”) in
cash or wire transfer of immediately available funds or (B) by
notifying the Company that this Warrant is being exercised pursuant
to a Cashless Exercise (as defined in Section 1(d)). The
Holder shall not be required to surrender this Warrant in order to
effect an exercise hereunder, provided that this Warrant is
surrendered to the Company by the second Business Day following the
date on which the Company has received each of the Exercise Notice
and the Aggregate Exercise Price (the “Exercise Delivery
Documents”). On or before the first Business Day
following the date on which the Company has received each of the
Exercise Notice and the Aggregate Exercise Price (or notice of a
Cashless Exercise) (the “ Exercise Delivery Documents
”), the Company shall transmit by facsimile an acknowledgment
of confirmation of receipt of the Exercise Delivery Documents to
the Holder and the Company’s transfer agent (the “
Transfer Agent ”). The Company shall
deliver any objection to the Exercise Delivery Documents on or
before the second Business Day following the date on which the
Company has received all of the Exercise Delivery
Documents. In the event of any discrepancy or dispute,
the records of the Company shall be controlling and determinative
in the absence of manifest error. On or before the third
Business Day following the date on which the Company has received
all of the Exercise Delivery Documents and after the Company has
received this Warrant (the “ Share Delivery Date
”), the Company shall, (X) provided that the Transfer Agent
is participating in The Depository Trust Company (“
DTC ”) Fast Automated Securities Transfer Program (the
“ FAST Program ”) and so long as the
certificates therefor are not required to bear a legend regarding
restriction on transferability, upon the request of the Holder,
credit such aggregate number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise to the Holder’s
or its designee’s balance account with DTC through its
Deposit Withdrawal Agent Commission system, or (Y), if the Transfer
Agent is not participating in the FAST Program or if the
certificates are required to bear a legend regarding restriction on
transferability, issue and dispatch by overnight courier to the
address as specified in the Exercise Notice, a certificate,
registered in the Company’s share register in the name of the
Holder or its designee, for the number of shares of Common Stock to
which the Holder is entitled pursuant to such
exercise. Upon delivery of the Exercise Delivery
Documents and surrender of this Warrant, the Holder shall be deemed
for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date such Warrant Shares are
credited to the Holder’s DTC account or the date of delivery
of the certificates evidencing such Warrant Shares, as the case may
be. If this Warrant is submitted in connection with any
exercise pursuant to this Section 1(a) and the number of Warrant
Shares represented by this Warrant submitted for exercise is
greater than the number of Warrant Shares being acquired upon an
exercise, then the Company shall as soon as practicable and in no
event later than five Business Days after any exercise and at its
own expense, issue a new Warrant (in accordance with Section 7(d))
representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant,
less the number of Warrant Shares with respect to which this
Warrant is exercised. The Company shall pay any and all
taxes that may be payable with respect to the issuance and delivery
of Warrant Shares upon exercise of this Warrant.
(b) Exercise
Price . For purposes of this Warrant, “
Exercise Price ” means $0.858 per share of Common
Stock, subject to adjustment as provided herein.
(c) Limitations on
Exercises . (1) The Company shall not
effect the exercise of this Warrant, and the Holder shall not have
the right to exercise this Warrant, to the extent that after giving
effect to such exercise, such Person (together with such
Person’s affiliates) would beneficially own in excess of
4.99% (the “ Maximum Percentage ”) of the shares
of Common Stock outstanding immediately after giving effect to such
exercise. For purposes of the foregoing sentence, the
aggregate number of shares of Common Stock beneficially owned by
such Person and its affiliates shall include the number of shares
of Common Stock issuable upon exercise of this Warrant with respect
to which the determination of such sentence is being made, but
shall exclude shares of Common Stock which would be issuable upon
(i) exercise of the remaining, unexercised portion of this Warrant
beneficially owned by such Person and its affiliates and (ii)
exercise or conversion of the unexercised or unconverted portion of
any other securities of the Company beneficially owned by such
Person and its affiliates (including, without limitation, any
convertible notes or convertible preferred stock or warrants)
subject to a limitation on conversion or exercise analogous to the
limitation contained herein. Except as set forth in the
preceding sentence, for purposes of this paragraph, beneficial
ownership shall be calculated in accordance with Section 13(d) of
the Securities Exchange Act of 1934, as amended (the “
Exchange Act ”). For purposes of this
Warrant, in determining the number of outstanding shares of Common
Stock, the Holder may rely on the number of outstanding shares of
Common Stock as reflected in (1) the Company’s most recent
Form 10-K, Form 10-Q, Current Report on Form 8-K or other public
filing with the Securities and Exchange Commission, as the case may
be, (2) a more recent public announcement by the Company or (3) any
other notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. For any
reason at any time, upon the written or oral request of the Holder,
where such request indicates that it is being made pursuant to this
Warrant, the Company shall within two Business Days confirm orally
and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to
the conversion or exercise of securities of the Company, including
the SPA Warrants, by the Holder and its affiliates since the date
as of which such number of outstanding shares of Common Stock was
reported. By written notice to the Company, the Holder
may increase or decrease the Maximum Percentage to any other
percentage not in excess of 4.99% specified in such notice;
provided , that (i) any such increase will not be effective
until the 61 st day after such notice is delivered to the
Company and (ii) any such increase or decrease will apply only to
the Holder and not to any other holder of SPA Warrants.
(2) No Exercise That Triggers
Pill . This Warrant may not be exercised to acquire
Warrant Shares to the extent that when added to those already
beneficially owned by the Holder for purposes of the Rights
Agreement dated as of September 7, 2001 between the Company and
American Stock Transfer & Trust Company (the “ Rights
Agreement ”), such Warrant Shares would cause such Holder
to become an Acquiring Person as that term is used in the Rights
Agreement with respect to that Holder.
(d) Cashless
Exercise . The Holder may, in its sole
discretion, but only at times the Registration Statement is not
effective or an exemption from registration is not available,
exercise this Warrant in whole or in part and, in
lieu of making the cash payment otherwise contemplated to be made
to the Company upon such exercise in payment of the Aggregate
Exercise Price, elect instead to receive upon such exercise the
“Net Number” of shares of Common Stock determined
according to the following formula (a “ Cashless
Exercise ”):
Net Number = (A x B) - (A x C)
For purposes of the foregoing
formula:
A= the total number of shares with respect to
which this Warrant is then being exercised.
B= the Weighted Average Price of the shares of
Common Stock (as reported by Bloomberg) for the five consecutive
Trading Days ending on the date immediately preceding the date of
the Exercise Notice.
C= the Exercise Price then in effect for the
applicable Warrant Shares at the time of such exercise.
(e) Disputes
. In the case of a dispute as to the determination of
the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number
of Warrant Shares that are not disputed and resolve such dispute in
accordance with Section 12.
2. ADJUSTMENT OF
EXERCISE PRICE AND NUMBER OF WARRANT SHARES . The
Exercise Price and the number of Warrant Shares shall be adjusted
from time to time as follows:
(a) Adjustment upon
Subdivision or Combination of shares of Common Stock
. If the Company at any time on or after the
Subscription Date subdivides (by any stock split, stock dividend,
recapitalization or otherwise) one or more classes of its
outstanding shares of Common Stock into a greater number of shares,
the Exercise Price in effect immediately prior to such subdivision
will be proportionately reduced and the number of Warrant Shares
will be proportionately increased. If the Company at any
time on or after the Subscription Date combines (by combination,
reverse stock split or otherwise) one or more classes of its
outstanding shares of Common Stock into a smaller number of shares,
the Exercise Price in effect immediately prior to such combination
will be proportionately increased and the number of Warrant Shares
will be proportionately decreased. Any adjustment under
this Section 2(a) shall become effective at the close of business
on the date the subdivision or combination becomes
effective.
(b) Other
Events . If any event occurs of the type
contemplated by the provisions of Section 2(a) but not expressly
provided for by such provisions (including, without limitation, the
granting of stock appreciation rights, phantom stock rights or
other rights with equity features to the holders of the
Company’s equity securities), then the Company’s Board
of Directors will make an appropriate adjustment in the Exercise
Price and the number of Warrant Shares so as to protect the rights
of the Holder; provided , that no such adjustment pursuant
to this Section 2(b) will increase the Exercise Price or decrease
the number of Warrant Shares as otherwise determined pursuant to
this Section 2.
3. RIGHTS UPON
DISTRIBUTION OF ASSETS . If the Company shall
declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common
Stock, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, stock or other securities,
property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or
other similar transaction) (a “ Distribution ”),
at any time after the issuance of this Warrant, then, in each such
case:
(a) any Exercise Price
in effect immediately prior to the close of business on the record
date fixed for the determination of holders of shares of Common
Stock entitled to receive the Distribution shall be reduced,
effective as of the close of business on such record date, to a
price determined by multiplying such Exercise Price by a fraction
of which (i) the numerator shall be the Weighted Average Price of
the shares of Common Stock on the Trading Day immediately preceding
such record date minus the value of the Distribution (as determined
in good faith by the Company’s Board of Directors) applicable
to one share of Common Stock, and (ii) the denominator shall be the
Weighted Average Price of the shares of Common Stock on the Trading
Day immediately preceding such record date; and
(b) the number of
Warrant Shares shall be increased to a number of shares equal to
the number of shares of Common Stock obtainable immediately prior
to the close of business on the record date fixed for the
determination of holders of shares of Common Stock entitled to
receive the Distribution multiplied by the reciprocal of the
fraction set forth in the immediately preceding paragraph (a);
provided , that in the event that the Distribution is of
shares of Common Stock or common stock of a company whose common
shares are traded on a national securities exchange or a national
automated quotation system (“ Other Shares of Common
Stock ”), then the Holder may elect to receive a warrant
to purchase Other Shares of Common Stock in lieu of an increase in
the number of Warrant Shares, the terms of which shall be identical
to those of this Warrant, except that such warrant shall be
exercisable into the number of shares of Other Shares of Common
Stock that would have been payable to the Holder pursuant to the
Distribution had the Holder exercised this Warrant immediately
prior to such record date and with an aggregate exercise price
equal to the product of the amount by which the exercise price of
this Warrant was decreased with respect to the Distribution
pursuant to the terms of the immediately preceding paragraph (a)
and the number of Warrant Shares calculated in accordance with the
first part of this paragraph (b).
4. PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS .
(a) Purchase
Rights . In addition to any adjustments pursuant to
Section 2 above, if at any time prior to the Expiration Date the
Company grants, issues or sells any Options, Convertible Securities
or rights to purchase stock, warrants, securities or other property
pro rata to the record holders of any class of shares of Common
Stock (the “ Purchase Rights ”), then the Holder
will be entitled to acquire, upon the terms applicable to such
Purchase Rights, the aggregate Purchase Rights which the Holder
could have acquired if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant
(without regard to any limitations on the exercise of this Warrant)
immediately before the date on which a record is taken for the
grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.
(b) Fundamental
Transactions . Upon the occurrence of any
Fundamental Transaction, the Successor Entit